Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | 0.00% |
|
-4.00% | +9.09% |
05:38am | PYC Therapeutics Completes Initial Dosing for Retinitis Pigmentosa Study | MT |
07-10 | PYC Therapeutics Begins Multiple Dose Trial for Blinding Eye Disease Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.09% | 376M | |
+25.83% | 47.96B | |
+46.00% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- PYC Stock
- News PYC Therapeutics Limited
- PYC Therapeutics Begins Multiple Dose Trial for Blinding Eye Disease Drug